These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7813552)

  • 1. An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H.
    Pugsley MK; Saint DA; Walker MJ
    Eur J Pharmacol; 1994 Aug; 261(3):303-9. PubMed ID: 7813552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat.
    Pugsley MK; Saint DA; Hayes ES; Kramer D; Walker MJ
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):863-74. PubMed ID: 9869491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of U50,488H on transient outward and ultra-rapid delayed rectifier K+ currents in young human atrial myocytes.
    Xiao GS; Zhou JJ; Cheung YF; Li GR; Wong TM
    Eur J Pharmacol; 2003 Jul; 473(2-3):97-103. PubMed ID: 12892826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart.
    Cheng L; Ma S; Wei LX; Guo HT; Huang LY; Bi H; Fan R; Li J; Liu YL; Wang YM; Sun X; Zhang QY; Yu SQ; Yi DH; Ma XL; Pei JM
    Heart Vessels; 2007 Sep; 22(5):335-44. PubMed ID: 17879026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
    Wilson JL; Nayanar V; Walker JS
    Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
    Yu XC; Wang HX; Pei JM; Wong TM
    J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U-50,488H, a kappa opioid receptor agonist, is a more potent blocker of cardiac sodium channels than lidocaine.
    Pugsley MK; Yu EJ; Goldin AL
    Proc West Pharmacol Soc; 2000; 43():47-50. PubMed ID: 11056955
    [No Abstract]   [Full Text] [Related]  

  • 9. [Delayed electrical uncoupling is involved in kappa-opioid receptor activation -induced cardioprotective effect in the isolated rat heart].
    Chen BP; Fan FY; Mao HJ; Xia Q
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 Feb; 22(1):64-70. PubMed ID: 21186583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
    Pugsley MK; Saint DA; Hayes ES; Abraham S; Walker MJ
    Eur J Pharmacol; 2015 Aug; 761():330-40. PubMed ID: 26086860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of kappa-opioid receptor mediated tolerance in the guinea-pig ileum by chronic co-administration of dihydropyridines.
    Garaulet JV; Laorden ML; Milanés MV
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):72-9. PubMed ID: 8832591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart.
    Zhang WM; Wang HX; Xia Q; Wong TM
    Br J Pharmacol; 1997 Mar; 120(5):827-32. PubMed ID: 9138688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. kappa -opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na(+)-H(+)exchange pathway.
    Bian JS; Pei JM; Cheung CS; Zhang WM; Wong TM
    J Mol Cell Cardiol; 2000 Aug; 32(8):1415-27. PubMed ID: 10900168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cardiac sarcolemmal Na+/H+ antiporter by opioids.
    Periyasamy SM
    Can J Physiol Pharmacol; 1992 Jul; 70(7):1048-56. PubMed ID: 1333352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of LY235959, a competitive antagonist of the NMDA receptor on kappa-opioid receptor agonist induced responses in mice and rats.
    Bhargava HN; Thorat SN
    Brain Res; 1997 Feb; 747(2):246-51. PubMed ID: 9045999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro- and anti-arrhythmic effects of a kappa opioid receptor agonist: a model for the biphasic action of a local hormone in the heart.
    Yu X; Zhang W; Bian J; Wong TM
    Clin Exp Pharmacol Physiol; 1999 Oct; 26(10):842-4. PubMed ID: 10549419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic effects of U-50,488H in rats subject to coronary artery occlusion.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Eur J Pharmacol; 1992 Feb; 212(1):15-9. PubMed ID: 1555635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioidergic modulation of voltage-activated K+ currents in magnocellular neurons of the supraoptic nucleus in rat.
    Müller W; Hallermann S; Swandulla D
    J Neurophysiol; 1999 Apr; 81(4):1617-25. PubMed ID: 10200198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptor independent inhibition of Ca2+ and K+ currents in NG108-15 cells by the kappa opioid receptor agonist U50488H.
    Carpenter E; Gent JP; Peers C
    Neuroreport; 1996 Jul; 7(11):1809-12. PubMed ID: 8905670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The actions of the kappa 1 opioid agonist U-50,488 on presynaptic nerve terminals of the chick ciliary ganglion.
    Fletcher GH; Chiappinelli VA
    Neuroscience; 1993 Mar; 53(1):239-50. PubMed ID: 8385747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.